8-Formylophiopogonone BCAS# 1316224-74-4 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 1316224-74-4 | SDF | Download SDF |
PubChem ID | 53468060.0 | Appearance | Powder |
Formula | C19H16O6 | M.Wt | 340.33 |
Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 5,7-dihydroxy-3-[(4-methoxyphenyl)methyl]-6-methyl-4-oxochromene-8-carbaldehyde | ||
SMILES | CC1=C(C(=C2C(=C1O)C(=O)C(=CO2)CC3=CC=C(C=C3)OC)C=O)O | ||
Standard InChIKey | HDJKXNHPMVFURN-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C19H16O6/c1-10-16(21)14(8-20)19-15(17(10)22)18(23)12(9-25-19)7-11-3-5-13(24-2)6-4-11/h3-6,8-9,21-22H,7H2,1-2H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
8-Formylophiopogonone B Dilution Calculator
8-Formylophiopogonone B Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.9383 mL | 14.6916 mL | 29.3832 mL | 58.7665 mL | 73.4581 mL |
5 mM | 0.5877 mL | 2.9383 mL | 5.8766 mL | 11.7533 mL | 14.6916 mL |
10 mM | 0.2938 mL | 1.4692 mL | 2.9383 mL | 5.8766 mL | 7.3458 mL |
50 mM | 0.0588 mL | 0.2938 mL | 0.5877 mL | 1.1753 mL | 1.4692 mL |
100 mM | 0.0294 mL | 0.1469 mL | 0.2938 mL | 0.5877 mL | 0.7346 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 5, 9-epi-Phlomiol
Catalog No.:BCX1346
CAS No.:1621908-70-0
- 9-epi-Phlomiol
Catalog No.:BCX1345
CAS No.:1621720-47-5
- 6β-Hydroxy-7-epiloganin
Catalog No.:BCX1344
CAS No.:125410-28-8
- 8-Geranyl daidzein
Catalog No.:BCX1343
CAS No.:1072940-16-9
- 3'-Methoxycoumestrol
Catalog No.:BCX1342
CAS No.:13360-66-2
- Paratocarpin K
Catalog No.:BCX1341
CAS No.:170900-13-7
- Linderanine C
Catalog No.:BCX1340
CAS No.:139681-96-2
- Dracaenoside F
Catalog No.:BCX1339
CAS No.:109460-83-5
- Phloyoside I
Catalog No.:BCX1338
CAS No.:139757-58-7
- rel-(+)-(1R,2Z,7Z,10S,11S)-10-(Acetyloxy)-7,12,12-trimethylbicyclo[9.1.0]dodeca-2,7-dien-4-one
Catalog No.:BCX1337
CAS No.:886439-01-6
- Gosferol
Catalog No.:BCX1336
CAS No.:37551-62-5
- Ilexoside XLVIII
Catalog No.:BCX1335
CAS No.:129095-76-7
- Volvalerenal E
Catalog No.:BCX1348
CAS No.:1247014-33-0
- Calycanthidine
Catalog No.:BCX1349
CAS No.:5516-85-8
- O-Methylbulbocapnine
Catalog No.:BCX1350
CAS No.:2490-83-7
- Yuanamide
Catalog No.:BCX1351
CAS No.:102421-42-1
- Umbelliprenine
Catalog No.:BCX1352
CAS No.:23838-17-7
- Kaempferol 3-O-β-D-glucopyranosyl-(1-2)-α-L-rhamnopyranoside
Catalog No.:BCX1353
CAS No.:142451-65-8
- Ajugamacrin B
Catalog No.:BCX1354
CAS No.:123313-59-7
- Eugenitin
Catalog No.:BCX1355
CAS No.:480-12-6
- (3R)-dihydroarteannuin B
Catalog No.:BCX1356
CAS No.:87206-33-5
- 6""-apiosyl sec-O-glucosylhamaudol
Catalog No.:BCX1357
CAS No.:2254096-95-0
- Cantleyoside
Catalog No.:BCX1358
CAS No.:32455-46-2
- Neokurarinol
Catalog No.:BCX1359
CAS No.:52483-00-8
An Efficient Regioselective Synthesis of 8-Formylhomoisoflavonoids with Neuroprotective Activity by Enhancing Autophagy.[Pubmed:33724036]
J Nat Prod. 2021 Apr 23;84(4):1385-1391.
6-Formylisoophiopogonone B (7a) and 8-Formylophiopogonone B (7b), two natural products isolated from Ophiopogon japonicus, represent a subgroup of rare 6/8-formyl/methyl-homoisoflavonoid skeletons. Herein we report an efficient method for the synthesis of these formyl/methyl-homoisoflavonoids. The synthesized compounds were evaluated for their neuroprotective effects on the MPP(+)-induced SH-SY5Y cell injury model and showed marked activity. Exploration of the neuroprotective mechanisms of compound 7b led to an increased expression of autophagy marker LC3-II and down-regulation of autophagy substrate p62/SQSTM1. Molecular docking studies showed that 7b may prevent the inhibition of the classic PI3K-AKT-mTOR signaling pathway by interfering with the human HSP90AA1.